Immune-Response Modifiers: Characteristics of High-Volume Prescribers

CONCLUSION: The 4 years' post-residency may be instrumental in helping providers become more comfortable in prescribing high volumes of biologic immune modifiers and OSMs. In addition, the higher volume prescriptions of both immune response modifiers by males may be due to males being more risk tolerant. J Drugs Dermatol. 2022;21(12):1283-1288. doi:10.36849/JDD.6891R1.PMID:36468964 | DOI:10.36849/JDD.6894
Source: Journal of Drugs in Dermatology - Category: Dermatology Authors: Source Type: research